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Conclusion: Data lno~ate thai infnflatc neural cholinerg~¢ I~lhways, inter, 
acting with cardiac tissue kallikmlrl-kinle ltyslem, canter 8n impe~lant auloreg. 
ulafory mechanism, involved in m~tating the ischem~ myocar~al adaptive 
procesS, 
11056-111 I Sloelmde of the Plat~l~t Oltmoprotain 
' ' Reeepler Reduce= Inf~m SIN In a ~nlne Model 
of l~Fwamlkll I n ~ l o n  and I~peduslon 
J,G Kleg~,  Jr,, S, Ranis, Po Bogaly,/.a~t Ungainly an# OuN~ec Heart 
~mme, S ~  G,d~x~, C m  
I~lCt~r01/t~; Plat¢lot gly¢opr0tei/tt I!b/ltl8 me'ephor (OP!ll~,qlla) bl0¢k~e ahows 
p ~ X ~  in Itt~ t!~k~lMle~ of acuto co~.,~a~ ~/ f~fom~ p~umat~y dge fo lfta, 
b~lization of ~ %'~9M" cOe0~ey 101~lUe, We m ~ l e d  whal~er M K . ~  
~ An~i~hetize~ o ~  do~ls u ~  ! h ~ W  oc- 
dus~r~ foftow~ ~ 3 h ,,~,~,t~n. The~ ~ (Stgm~p) were ~ ;  
! - h e t ~  (HEP; 100 g~ l~ ) ,  ~MK ~r HEP ax~ 3~MK, MK wa~ gwen tV at 
~ ~ ~ m n  (~;!0 .g/Ko ove~ 3 mat fo,'lowe¢l by 3 . ~ K ~  foe 3 h), 
Collateral blood fl0w (aF; mlJm~g) was measured al 30 mm of o c c l ~  
(u=ng mm~zpttm~), ~ (I) was ~ u=ng ~lraz~hwn st=ring 
and ~ i z ~ d  to area at mk lAIR; Moaastral blue dye), 
F~,m~S- C o ~  hemodynam~, BF and AR (mean ± SEM) did nol 
differ I:~l~e~m ~ ;  in dogs ~ MK alone. I ~  ~!atmn b e ~ n  BF and 
iofa¢l size was shifted ~ r d  (Ip = 0003 vs. HEP. ANCOVA) indicating 
can:liopmtectton. 
Coaate~zd I~  AR tc-~l UAR 1%) 
HEP 004±O01  4 8 3 ¢ 1 5  28.8¢3.8 
MK* HEP 0.08 ± 003 458¢2 .3  23.0±2.5 
IdK 0 0~ :t. 0.02 4 8 0 ± 2 7  14.4¢1955 
Conctm~ons: GPIIMIla blockade s~uficantty reduced t~'ue nesmsrs. 
These dat~ doc.m~"tt an additional mechanism of benefit for anti-l~lalelel 
aggregatin9 agents in acute corona w syndromes. 
~ Serum Profi les o f  Pmin f lammatory  Cytokines 
and Their SOluble Receptors According to the 
Severi ty o f  Acute M~ : :a rd l a l  Infarct ion 
J. Panss~S, K~ Ve~etsanou, D. Menlzikol, N Zims, K. Merkouns, C. Kefalas. 
S. Karas. Amalia Fleming Hos~tal and St. Anargm Hospital, Athens. Greece 
Background: Cytokines am known tO regulate the mflammalo~/ and sub- 
sequent proliferative responses o1 patients wdh acule myocardial intarctmn 
(AMI). This sludy investigales the I~netics of prolnftammafon/cytolunes, such 
as lntedeukin-6 ([L-6) and Tumor Necrosis Factor-a (TNF-a), and their so~u- 
hie receptors in pagents with AMI m relation to the seventy of the disease. 
MethoO~: Setrum concentrallons Of IL-6. TNF-a. soluble IL-6 m~,;~p;o¢ 
(sIL-6R) and soluble TNF receptor t (sTNFRI) were delerm~rted in 31 AMI 
patients (20 men and 11 women; age: 37-75 years) w~heut present tuslo~ of 
infection or malignancy by enzyme linkend immunosodaent aasay during the 
first week of hospitalization. Patients of group A (n = 16) had uncanceled 
AMI (Killip class 1) while patients ol group B (n = 15) had severe AMI (Killip 
class >_2). Finally, 10 age-matched volunteers were used as healthy controls. 
Result&" Peaks of IL-6 and slL-6R levels ware not sigrMicantty different 
between the two groups ilL-6: group B 25.2 ± 4.7 vs group A 23 ± 4.3 I ~ 1  
and slL-6R: group B 3.6 • 0.3 vs group A 3.9 • 0 6 noJml, p = NS) but ware 
signi{~cantty higher than the respectnm levels of healthy controls ilL-6:3.9 ± 
0.5 pojmh p < 0.01; slL-6R: 1.7 ~: 0.3 ng/ml, p < 0.05). Furthermore, peaks of 
TNF-a and sTNFRI levels were signil¢.antly higher in group B than respective 
peaks ot cylokine levels in group A (TNF-a: group B 19.2 :~ 3.7 vs group A 
6.2 :~ 1.7 pg/ml, p < 0.01; sTNFRI: group B 4.1 ~ 1.1 vs group A 2.9 ± 0.6 
ng/ml, p < 0.01) and healthy controls (TNF-a: 3.5 • 1.1 Wml and sTNFRI: 
1.9 • 0.1 ng/ml, p -~ 0.001). In group B regression analysis revealed that the 
peak of TNF-a levels significantly correlated with peak of sTNFRI levels (r = 
0.60, p < 0.01), white blood cell counts (r = 0.50, p ~ 0.05), peak of serum 
CK MB isoenzyme (r = 0.67, p ,~ 0.01) and ejec,=on fra,.'tmn (r = -0.61, p - 
0.01). In the same patients, the peak ol sTNFRt lev=ls was also significantly 
correlated with white blood cell counts (r = 0.60, p ~- 0.01), peak o1 serum 
CK MB isoenzyme (r = 0.63, p < 0.01) and ejection fraction (r = -0 .65,  p < 
0.01). Finally, in group B, non survivors (n = 4) had significantly higher peaks 
of TNF-a and sTNFRI levels (both p < 0.05) than those of survivors (n = 11). 
Conclusions: These results suggest that proinflammafory cytokine serum 
activity increases substantially in the two catergories of AMI and TNF-a is a 
major cytokine which may be especially implicated in the pathophysiology of 
severe AMI. This cytokine and its soluble receptor closely correlated with AMI 
severity anci worsening prognosis and may be used as alternative prognostic 
indicators of severe AML 
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HV. IB~fon, SR Ptrrad~ D J, L o m t ~  NR, Every, J,M Oom, TrM, C1~Y¢1 
U r ~ y  0t Cam~wa, S~n ~ an~Ger~eme~ t,c S ~  Sa~ 
Fra,~o, Cam~m~ US4 
~ .mound :  P a ~ t ~  w~h acute m y o c a ~  mtaect~pe (AMI) comlp~te~ 
by card~ogen¢ aback (CGS) have= d~mm=~ mmea~y p a ~  pe~,surs 
wh~h may lira4 I ~  e ~  ot ~l~ysNwl~y I~rl~nlstered t h ~  
balloon countaq~ulsation (!ABP) Is assooaled wrth m~l~OVed smvival in auch 
Method: Using data from ft~e Nalmnal Regml~y o1 Myeeam'tal thfamlmn 
2. we Klentltied 21,711~ p a ~  with AMI who ~ with of developed 
CGS wh~e m hosptaL 
Resu~: Of Ihe 21,178 patients RlentWted, 6,993 (3~,~) ~ IABP 
Pabents who ~ IABP were ~ (66.6 vs 73.S), morn oflee male 
(60% vS 50%) and i'~,ce as Ulu~y to rece4ve ~ TT of pm~Ify PTCA 
(PPTCA) (56% vs 28%). While IABP was azl~¢zatad ~ a ~ g'ptlo=P 
pdal modalify rate in pabents who mcelved I"I" (69 vs 49, p < 0.001), I t~  
was not obser~d m ~ who ~ PPTCA (44% vs 47%, p = ns). 
Theee f, xllege pars~led after cone~ng fo~ baselme d~ftereeces bmween 
the groupS. 
~ o o  
T I ' +  PP'UC'A PPTCA 
IABP + IABP 
Conc/us~ns: The use of IABP m patients w~h AMI complmated by car- 
dmgen~ shock is associated w~th a ma~ecl reductmn in nmrtalW when used 
m com~natlon with lhrombolylm therapy. ~ r ,  the use of IABP is not 
asse~aled w~h improved survwal m pahems ur~ergomg PPTCA 
I 1057:126', PredictOrS o f  Free Wall Rupture in Acute In,%,rior 
! ! Myoemdm mfamUon 
R. Ldpez-Palop, E. Perez*Dav~, H. Buena. J. Garcia-Garcia, M.M. Setles, 
J L  L0pe:-Send0n, J.L Delc~n. Hosio~l Genera/"Gragotm Marar'~n °, 
Madr/d. Spa/n 
Background: Left ventncular free wall rupture (FWR) m an infrequent and gen. 
eralty lethal complication of AMI. t.am ~ therapy, advanced age, 
lateral Iocattofl of AMI are clfflical fealures associaled wdh its oo=un, ence, 
The mm of this study is to determine the clinical and eleofrecardiegraph¢ 
prediclors of FWR m acute myocardial klP=K.;;on of inferior focation (IMI), 
Methods: The i ~  arid clinK:at pfeC~ors of F~NR were studflB¢l in 
808 c o n ~  patients (pts) with Q-wave IMI of less man 48 hours of 
evolution admitted from 1991 to 1995 to our CCU. 
Resuffs: Mean age was 64 ~ 12 years, 78% wore men. Repedusion 
treatment was used in 54% o! pts. In-hospital case fatality rate was 12.4% 
in the whole cjn~p. 26 I~s developed FWR (3.2%) whch was lalal m 22 
cases (85%). A multiple logistic regression analysis which also included sex, 
prewouS MI, d_~iabetes, hype[ter, s;o~ and i,_l:~usron ~,~va~/selected age, 
ST segment elevahon in V~-Vs leads on admission ECG and time delay 
from symptom onset to CCU admission as independent predictors o! FWR 
development. ST segment elevation in Vs-V~ leads remained as a predictor 
of FWR when only pts admitted eadier than 24 hours and than 12 hours from 
symptom onset ware considered 
Odds raho 95% CI P 
Vs-V s ST elevation 3.1 1 3.-7 t .0.008 
l~me pelay (per hour) 1 03 1 004-I.07 <0 03 
Age (per year) 104 101-1.08 - 004 
Conclusions: ST ~egment elevation in Vs-V6 leads is a very powerful 
predictor of FWR development in pts with IML Advanced age and a longer 
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time deftly to CCU admission are also associated with a higher incidence of 
this mochnnicel complication, 
~ - 5 ~  Lack of Progress In Card logenlc  Shock: 
' Lessons From the GUSTO Trials 
V, Menen, J,S, Hechmnn, D.R, Holmes, Jr,, E,R, Bates, R,D, Anderson, 
R,M, Califf, E,J, Topoi, E, Magnus, Ohman for the GUSTO. III Investigators; 
SL Lttke~.Roesev~/t Ho,~ptml Center, Col(/mbia University, New York, NY, 
USA 
We evekmted the Incldenco, procedure utlllzatlen and outcomes of pm 
tionts wllh cmdlegenic t~hack (CS) in GUSTO.Ill (tg05-97) ~nd GUSTO-1 
(1990-93) In an nn~ly~ls re~trlgted 1o countrie~ that participated in both= The 
805 (5,5%) pnttsnte with CS in GUSTO.Ill were older (69 :t 11,7 v 07 ~ 
11,1 ym, p .  0,0001) thnn the 2972 patients (7,2%) In GUSTO.1 with more 
diabetes (23 v 10%, p .  0,015) end I~ypertensten (48 v 44%, p ,~ 0.0?.), Prior 
CABG (5,2% v 6,5%), prior MI (~8 v ;~5%), prior PTCA (4,3 v 3,5%) entry 
dt~t01te BP (71,3 :t: 18,5 v 71,6 :t 17.1 ram) and HR (836 :t 23,5 v 82,1 
22,1) were comparable, GUSTO.Ill p~tienfa ware morn likely to I~avo an 
index anterior lnfnmtien (60 v 51%, p ~ 0,0000~) wllh increased entry ~ysfolie 
BP (t19 ~ 28 v 115,3 :t ;~7 ram, p =~ 0,0004) and had lean lelt (39 v 46%, p 
= 0,002) ,~nd nghl (~9 v 44%, p ,= 0,0000001) hnnrt eathelentntten and less 
vantllatow sz~pport (41 v 48%, p ~ 0,0004), De~ptIe ,Imllar mice of PTCA (19 
v 19%), CABG (11 v 1~%), and IABP (24 v ~5%), mortality (6~ v 55%, p = 
0,00~), rolnfnrotten (14 v 10%, p = 0,012) and recurrent iachemm (35 v 26%, 
p =~ 0,0OOOl) In GUSTO.Ill worn elgnilioantly higher Moan LOS m survivors 
was 11,P. ~ 9,3 days in GUSTO.Ill va 17,7 :t 1£~,5 ( p .  0,091) ~n GUSTO.l. 
COncl¢~slen; Increased age and morn anterior inlamtian may have con. 
trlbuted to Incmn~od mortality and morbidity in GUSTO.Ill, Overall mortality 
for CS with ~Ctlfe MI in large clinical Ihrombolytic trials has not decreased 
over the last seven years 
~ Correlation of Clinical and H e m o d y n a m l c  
Findings and  O u t c o m e  In Cardlogenlc S h o c k  
v Menon, L A  Steeper, D, Hart, J Wobb. J,S, Hochman, Forths SHOCK 
inv~StlgMom Saint Luke~.Reo~evelt Hospital Center, New '~t)rk, NY, USA 
A.~ Cardlegentc Shock (CS) constitutes a spectrum of LV failure we eorrelalod 
clinical findings and homodynamie function in a et~bsot of 337 patients m the 
SHOCK Reglslry w~lh suspected predomlnaot LV CS following acute MI, 
Clinically. 7 patients had ne pulmonary congestion (PC) or hypopodusion 
(HP) (grpl), 13 had isolated PC (grp2), 90 had isolated end organ HP (grp3) 
and 227 had HP with PC (grp4), 86% Grpl, 65% Grp2, 59% Grp3 and 62% 
Gq:~l patienls had Swan Ganz Calhntortznbon. GIp 3 v grp4: mean PCWP 
was 19.7 t 63 vs 25.2 t 85  mm (p = 0.001), Cardiac Index 1.9 t. 0.6 vs 
21 t 0,7, (p = 0,095), lowest systolic BP was 62,7 ± 23 vs 69,4 ~ 17 mm. 
p = 0,006 andHR 90.9 ~ 27v96,8  , 26, (p=008).  Wocomparedgrps 
3 & 4 by untv~rlato analysis and found similar ago (68,3 t: 11.8 v 69.7 t 
10.8 yrs), thmmbolytic eligibility (53.3 v 49.8%), cigarette smoking (548 v 
58.2%), and use o! IABP (54.4 v 53.7%), angiography (60,0 v 639%), PTCA 
(3,'3,6 v 28.6%) and CABG (13.3 v 16.3%). Mortality was higher in grp 3 
(68.9 v 59.5%, p = 0.125) despile loss peer MI (35.4 v 48.6%, p = 0.048), 
diabetes (19.8 v 33,8%. p = 0.018) and CHF (12.2 v 26.7%, p = 0.008). After 
adjustment far 1hose variables, grp 4 mortality was significantly lower: Odds 
ralio 0.49, 95% CI (0.27, 0.89), p = O0t9 despite receiving similar treatment, 
Conclusion: The clinical subset with hypopartusion and no pulmonary con- 
gestion constitulos a major cohort of CS and is associated with significanlly 
higher mortality, The explanation tar this requires further investigation. 
~ - 9 - ]  Risk of Mor ta l i t y  A m o n g  Surv ivors  o f  In -hosp i ta l  
- Ventrlcular Fibrillation After Myocardial 
Infarction Is Highly Time Dependent  
GVH.  Jansen, L. Kober, C, Torp-Pedersen. On behalf of the Trace study 
g~o(~p. Sept, of Cardiology, Hv~dovre University Hospital, Dept. of 
Cardiology, Gentefte University Hospital Copenhagen, Denmark 
Background: The aim of this study was to examine how long time after Acule 
Myocardial Infarction (AMI) Ventricular Fibrillation (VF) is a valid prognostic 
factor, since this could be important for timing of intervention, 
Methods: 6676 patients wilh enzyme venfied MI were screened consecu. 
rivet V for the Trandotaprd Cardiac Evalua~,on Study (TRACE) from 1990-1992 
in 27 Danish cenlres. Complications during hospilal slay were registered 
prospectively for all patients and survival information was obtained from the 
Danish Central Personal Registry July 15th 1994. 
Results: 6364 palients survived 96 hours after AMI. Among these 414 had 
VF in hospital. Patients with late VF ~ 48 h after AMI had an 30 days mortality 
on 73% comparing with 26% among patienls with early VF • 48 h after AMI. 
Among survivors q6 hou~ after AMI we analysed the, importance of VF wilh 
Inclusion of the following confounding risk factors: age, gender, history of 
hypertension, heart failure, atrial fibrillation, wall motion index, tnlarct slzo, 
infarct location and effect of thmmbetyeis in Cox-models. Relative risk (RR =- 
hazard mite) of VF for prediction el mortality between 5-10 days after AMI, 
10-20 days after AMI and 20-30 days after AMI or later (up to 4 years) were 
estimated: 
n # Hazard ratio HRzerd r~tie Hnzar~ mlio H~tz~lrd ratio 
(05% KIt (05% KIt (95% KIt (95% Kit 
VF 5-t0d~ys 11~20 day# ~1-30 dAY~ ~.30 d~yS 
~ffnr ^ MI ~ttar AMI ~ffer AMt ~lor AMI 
VF 414 3,13(~,(~=5,0)" 54(3,6=78)" 1,5(0,7~31)n~ t,l(0=0-d:4)ns 
EnrlyVF ~111] t,0(t,1-~L1)' ~ f t t t -~, f l ) '  OO(O,3-~,~)ns 11108~1Atns 
L/tin VF 110 6,5 (4,5~-0 B)" 14~ n 194=g.1 5)" 4,311~5-t1:6)' 1:1 (0,?-t,l~)n~ 
PrimnwVF lfi~ ?,4(42~1,1~1'" e~(4,~-1A,~)" 0OIO, I-~Lg)ns t4108-;P.4)ns 
9acnndmyVF 2Cll ~,Att,t)-,4,O)" 4~61~0~69t '" t,?(0,A-3,Ttns, tO(O8-t,:l)ns 
'p ,  0,05, "p • 00001, na non-significant 
Cenchlsmn: VF, early or Into, pnmery or s~condan/to congestive heart 
failure did not ~ffect prognosis of sun.avers longer than 30 days alter infamtion 
in the Trneo scroent=~g poptllatien, Stnco any intervention have the best 
cl~aeco fe mlnimite ~n ete~'~lte'~/risk, intolvont=ens based on sup~tva! after VF 
~hsuld probably therefore t~ko place early after fho event 
[ •  Incidence end Short-term Prognosis of Late 
- -  - -  Sustained Ventrlcular l'achycardla After 
Myocardial Infsmtion, Results From G!SSI-3 
Database  
A, Vofpi, A Cavalli, R, Turalo, S Badora, E Santoro. E Nags. Onbehatfof 
GISSI-3 Inv~stigatot~: ANMCO and M Necjrr Inst#tute, Florence and Mit,~n. 
/tat), 
~ckgmund. There iS scanty tnfermalion Irem large multiconter databases re- 
garding 1he incidence and prognosis of late sustained vontncutar lacnycar~a 
(LSVT) after myocardial inlamlion (MI). 
Methods: The incidence and short4erm prognosis of LSVT (.30 s~,c at 
a rate of ,~: 120 beats/mint was evaluated in 16,842 GISSI-3 patients t,~th a 
definite MI. 
Rear, Its: The incidence rate ot LSVT (time window: = 48 h to 6 vmeks) was 
0.9%. Older ago, delayed admission to CCU, a history of hypertension, dia- 
betes and MI, non administration of lyric therapy, Killip class ..1. ::6 leads with 
ST elevation, higher heart rate and bundle branch block on admission were 
signifieanlly more frequent among patients wdh than without LSV'T. Patients 
with LSVT had a significant excess of left venmcular failure, cardiogen=c 
shock, persistent hypotension, areal flutter-fibrillation, asystole, heart block 
and recurrent ischemia. Death rates by 6 weeks were 34.7% for patients 
wilh LSVT and 4 7% for those without the arrhythmta. On logistic regression 
analysis adiustlng tot the main clinical and ep=demlological vanabtes LSVT 
was retained as an independent predictor of @week mortality (RR 6.13; 95°° 
CI 4.56-..8.25). 
Conclusion: 1) A low incidence of LSVT was observed in the GISSI-3 
population; 2) the arrhythmia is a strong independent predictor of short-term 
mortality after ML 
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1 0 5 8 - 1 4 9  J U l t rason ic  In tegrated B a c k s c a t t e r  Ident i f ies 
t 
Prompt l y  Ef fects  o f  C o r o n a r y  A r te ry  
Reper fus ion  A f te r  Acu te  Myocard ia l  In farc t ion  
H -U  Stempfle, U Buchmeier, C Wemer, J. Schopohl, C E Angermann. 
K Theisen. University of Munich, Germany 
Background: Early recovery of regional cardiac function after coronary artery 
mvascuk ;ization in acute myocardial infamtion (AMI) has significant influ- 
ence on long-term survival, Cyclic variation of integrated backscafter (CVIB) 
reflects regional myocardial contractile performance which is blunted after 
arterial occlusion and recovers after mpeffusion. The aim of this study was 
to evaluate whether CVIB can promptly identify beneficial effects of coronary 
artery revascularization therapy after AMI. 
Methods: Ultrasonic 2D-IB-images (LV long & short axis, 2 & 4 chamber 
view; one cardiac cycle each) were obtained in 14 patients (4 f, 10 m, 
mean age: 63 ~ 11 yrs.) in our intensive care unit 5.2 ~- 2.1 hrs. after 
